PEOPLE ON THE MOVE
Quanterix
Diagnostics business Quanterix has appointed Kevin Hrusovsky, its current Executive Chairman, as Chief Executive Officer.
The company uses single-molecule measures to detect proteins for research and testing applications.
Hrusovsky has over 20 years of experience in life sciences. Before joining Quanterix, he oversaw several acquisitions and divestitures during his time as President of Life Sciences and Technologies at PerkinElmer, CEO of Caliper Life Sciences, and CEO of Zymark.
“I am honored to be with Quanterix, and believe we are poised for compelling growth and value creation,” said Mr. Hrusovsky. “Since launching our game changing ‘bleed to read’ RUO instrument and establishing a comprehensive IVD partnership with bioMérieux, we have seen rapid growth in many different therapeutic categories demonstrating its broad potential to transform healthcare.”